MED
Medifast Inc

1,791
Mkt Cap
$130.03M
Volume
564,878.00
52W High
$19.35
52W Low
$10.36
PE Ratio
591.39
MED Fundamentals
Price
$12.36
Prev Close
$11.83
Open
$11.92
50D MA
$12.04
Beta
0.68
Avg. Volume
199,122.11
EPS (Annual)
$0.1907
P/B
0.63
Rev/Employee
$1.2M
Loading...
Loading...
News
all
press releases
OPTAVIA Survey Reveals 80% of Americans Lack Understanding of Metabolic Health Despite Its Major Impact to Overall Health and Wellbeing
OPTAVIA, the science-backed, coach-guided lifestyle system, announced a new report Metabolic Health in America: Awareness, Attitudes and Action. The report includes findings based on an online survey...
Business Wire·4d ago
News Placeholder
More News
News Placeholder
Medifast (NYSE:MED) Upgraded at Wall Street Zen
Wall Street Zen upgraded Medifast from a "sell" rating to a "hold" rating in a report on Saturday...
MarketBeat·7d ago
News Placeholder
Tempus AI Boosts Its Clinical AI Capabilities Through Strategic Moves
TEM expands its clinical AI reach through regulatory wins, a new oncology partnership and a major digital-pathology acquisition.
Zacks·8d ago
News Placeholder
Hims & Hers Expands Care Scope as Digital Health Platforms Evolve
HIMS expands into low testosterone and menopause care, with plans for longevity and global growth in 2026.
Zacks·18d ago
News Placeholder
Medifast Scientific & Clinical Affairs Team Showcases New Research in Metabolic Health at ObesityWeek Conference
Medifast, the health and wellness company known for its science-backed, coach-guided lifestyle system, continues to lead the charge in addressing the growing health crisis of metabolic dysfunction by...
Business Wire·29d ago
News Placeholder
Medifast (NYSE:MED) Downgraded by Wall Street Zen to "Sell"
Wall Street Zen downgraded Medifast from a "hold" rating to a "sell" rating in a report on Saturday...
MarketBeat·1mo ago
News Placeholder
Medifast's Q3 Loss Wider Than Expected, Sales Decline 36% Y/Y
MED's third-quarter results reflect pressure from fewer active OPTAVIA Coaches, but it is steering toward metabolic health for growth.
Zacks·1mo ago
News Placeholder
Medifast Announces Third Quarter 2025 Financial Results
Medifast (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, today reported results for the third quarter ended September 30, 2025. Third Quarter...
Business Wire·1mo ago
News Placeholder
Hims & Hers Scales AI-Driven Personalized Health and Wellness
HIMS scales AI-driven care with new hormonal health lines, global expansion plans and a $870 million funding boost.
Zacks·1mo ago
News Placeholder
Medifast Announces Strategic Shift to Metabolic Health with the Introduction of Metabolic Synchronization
Medifast (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, today announced a strategic transformation, unveiling a new focus on holistic...
Business Wire·2mo ago

Latest MED News

View

Advertisement|Remove ads.

Advertisement|Remove ads.